Outset Medical, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Outset Medical, Inc. (OM) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -0.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-02-13
- Outset Medical, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2025 was -0.90%, a 164.29% decline from fiscal 2024.
- Outset Medical, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was 1.40%, a 7.69% increase from fiscal 2023.
- Outset Medical, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was 1.30%, a 7.14% decline from fiscal 2022.
- Outset Medical, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was 1.40%, a 16.67% increase from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.90% 10-K · filed 2026-02-13 | |
| 2024-12-31 | 1.40% 10-K · filed 2026-02-13 | |
| 2023-12-31 | 1.30% 10-K · filed 2026-02-13 | |
| 2022-12-31 | 1.40% 10-K · filed 2025-02-28 | |
| 2021-12-31 | 1.20% 10-K · filed 2024-02-21 | |
| 2020-12-31 | 1.00% 10-K · filed 2023-02-13 | 0.50% 10-K · filed 2021-03-22 |
| 2019-12-31 | 0.90% 10-K · filed 2022-02-23 | |
| 2018-12-31 | 2.00% 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |